Last 12 months
Inside the activity.
0 purchase rows · 3 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 02, 2018 Filed Apr 4, 2018 20:47 UTC |
MONTGOMERY RICE VALERIE MDDirector
|
GrantCommon Stock | 202 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-023718 · doc4.xml · nonDerivative · entry 1 MONTGOMERY RICE VALERIE MD · CIK 0001714561 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 543 F1 · shares: Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until the director's completion of service on the Board. Read SEC document |
| April 02, 2018 Filed Apr 4, 2018 20:47 UTC |
RENWICK GLENN MDirector
|
GrantCommon Stock | 375 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-023722 · doc4.xml · nonDerivative · entry 1 RENWICK GLENN M · CIK 0001198119 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,066 F1 · shares: Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until the director's completion of service on the Board. Read SEC document |
| April 02, 2018 Filed Apr 4, 2018 20:48 UTC |
Shine Kenneth IrwinDirector
|
GrantCommon Stock | 202 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-023724 · doc4.xml · nonDerivative · entry 1 Shine Kenneth Irwin · CIK 0001455025 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,150 F1 · shares: Represents shares of common stock that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Read SEC document |
| April 02, 2018 Filed Apr 4, 2018 20:49 UTC |
WILENSKY GAIL RDirector
|
GrantCommon Stock | 202 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-023727 · doc4.xml · nonDerivative · entry 1 WILENSKY GAIL R · CIK 0001018538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,677 F1 · shares: Represents shares of common stock that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Read SEC document |
| March 29, 2018 Filed Mar 30, 2018 20:17 UTC |
BURKE RICHARD TDirector
|
Exercise / conversionNon-Qualified Stock Options (right to buy) · Derivative | 5,000 | $0.00 Strike: $36.25 | $0.00 |
DisclosureSEC source: 0001209191-18-022208 · doc4.xml · derivative · entry 3 BURKE RICHARD T · CIK 0000905023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2018-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 29, 2018 Filed Mar 30, 2018 20:17 UTC |
BURKE RICHARD TDirector
|
Exercise / conversionCommon Stock | 5,000 | $36.25 | $181,250.00 |
DisclosureSEC source: 0001209191-18-022208 · doc4.xml · nonDerivative · entry 1 BURKE RICHARD T · CIK 0000905023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,776,331 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 20, 2018 Filed Mar 21, 2018 20:21 UTC |
BALLARD WILLIAM C JRDirector
|
GrantCommon Stock | 74 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-021074 · doc4.xml · nonDerivative · entry 1 BALLARD WILLIAM C JR · CIK 0001024398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,711 F1 · shares: Represents dividend equivalents paid on vested deferred stock units. The dividend equivalents are immediately vested and are subject to the same terms as the underlying deferred stock units. Read SEC document |
| March 20, 2018 Filed Mar 21, 2018 20:22 UTC |
BURKE RICHARD TDirector
|
GrantCommon Stock | 74 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-021075 · doc4.xml · nonDerivative · entry 2 BURKE RICHARD T · CIK 0000905023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,771,331 F2 · shares: Represents dividend equivalents paid on vested deferred stock units. The dividend equivalents are immediately vested and are subject to the same terms as the underlying deferred stock units. Read SEC document |
| March 20, 2018 Filed Mar 21, 2018 20:23 UTC |
FLYNN TIMOTHY PATRICKDirector
|
GrantCommon Stock | 6 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-021078 · doc4.xml · nonDerivative · entry 1 FLYNN TIMOTHY PATRICK · CIK 0001550322 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,531 F1 · shares: Represents dividend equivalents paid on vested deferred stock units. The dividend equivalents are immediately vested and are subject to the same terms as the underlying deferred stock units. Read SEC document |
| March 20, 2018 Filed Mar 21, 2018 20:23 UTC |
HOOPER MICHELE JDirector
|
GrantCommon Stock | 96 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-021079 · doc4.xml · nonDerivative · entry 1 HOOPER MICHELE J · CIK 0001201723 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,380 F1 · shares: Represents dividend equivalents paid on vested deferred stock units. The dividend equivalents are immediately vested and are subject to the same terms as the underlying deferred stock units. Read SEC document |
| March 20, 2018 Filed Mar 21, 2018 20:24 UTC |
LAWSON RODGER ADirector
|
GrantCommon Stock | 69 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-021081 · doc4.xml · nonDerivative · entry 1 LAWSON RODGER A · CIK 0001187442 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,833 F1 · shares: Represents dividend equivalents paid on vested deferred stock units. The dividend equivalents are immediately vested and are subject to the same terms as the underlying deferred stock units. Read SEC document |
| March 20, 2018 Filed Mar 21, 2018 20:25 UTC |
MONTGOMERY RICE VALERIE MDDirector
|
GrantCommon Stock | 2 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-021084 · doc4.xml · nonDerivative · entry 1 MONTGOMERY RICE VALERIE MD · CIK 0001714561 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 341 F1 · shares: Represents dividend equivalents paid on vested deferred stock units. The dividend equivalents are immediately vested but must be retained by the director until the director's completion of service on the Board. Read SEC document |
| March 20, 2018 Filed Mar 21, 2018 20:26 UTC |
RENWICK GLENN MDirector
|
GrantCommon Stock | 141 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-021085 · doc4.xml · nonDerivative · entry 1 RENWICK GLENN M · CIK 0001198119 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,691 F1 · shares: Represents dividend equivalents paid on vested deferred stock units. The dividend equivalents are immediately vested and are subject to the same terms as the underlying deferred stock units. Read SEC document |
| March 20, 2018 Filed Mar 21, 2018 20:28 UTC |
Shine Kenneth IrwinDirector
|
GrantCommon Stock | 96 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-021086 · doc4.xml · nonDerivative · entry 1 Shine Kenneth Irwin · CIK 0001455025 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,948 F1 · shares: Represents dividend equivalents paid on vested deferred stock units. The dividend equivalents are immediately vested and are subject to the same terms as the underlying deferred stock units. Read SEC document |
| March 20, 2018 Filed Mar 21, 2018 20:29 UTC |
WILENSKY GAIL RDirector
|
GrantCommon Stock | 70 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-021088 · doc4.xml · nonDerivative · entry 1 WILENSKY GAIL R · CIK 0001018538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,475 F1 · shares: Represents dividend equivalents paid on vested deferred stock units. The dividend equivalents are immediately vested and are subject to the same terms as the underlying deferred stock units. Read SEC document |
| March 20, 2018 Filed Mar 21, 2018 20:30 UTC |
HEMSLEY STEPHEN JDirector · Executive Chair of the Board
|
GrantCommon Stock | 398.862 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-021089 · doc4.xml · nonDerivative · entry 1 HEMSLEY STEPHEN J · CIK 0001180162 · Director · Executive Chair of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,548,019.183 F1 · shares: Represents dividend equivalents paid on outstanding deferred stock units and restricted stock units. The dividend equivalents are subject to the same terms as the respective underlying units and are forfeited if such units do not vest. Read SEC document |
| March 20, 2018 Filed Mar 21, 2018 20:31 UTC |
Nelson Steven HEVP & CEO, UnitedHealthcare
|
GrantCommon Stock | 59.956 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-021090 · doc4.xml · nonDerivative · entry 1 Nelson Steven H · CIK 0001320490 · EVP & CEO, UnitedHealthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,279.412 F1 · shares: Represents dividend equivalents paid on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if such units do not vest. Read SEC document |
| March 20, 2018 Filed Mar 21, 2018 20:32 UTC |
RENFRO LARRY CVice Chmn, UHG and CEO, Optum
|
GrantCommon Stock | 101.929 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-021091 · doc4.xml · nonDerivative · entry 1 RENFRO LARRY C · CIK 0001235046 · Vice Chmn, UHG and CEO, Optum 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 173,330.559 F1 · shares: Represents dividend equivalents paid on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if such units do not vest. Read SEC document |
| March 20, 2018 Filed Mar 21, 2018 20:34 UTC |
REX JOHN FEVP Chief Financial Officer
|
GrantCommon Stock | 75.341 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-021092 · doc4.xml · nonDerivative · entry 1 REX JOHN F · CIK 0001676672 · EVP Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,726.776 F1 · shares: Represents dividend equivalents paid on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if such units do not vest. Read SEC document |
| March 20, 2018 Filed Mar 21, 2018 20:34 UTC |
ROOS THOMAS EChief Accounting Officer
|
GrantCommon Stock | 64.475 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-021093 · doc4.xml · nonDerivative · entry 1 ROOS THOMAS E · CIK 0001651737 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,034.349 F1 · shares: Represents dividend equivalents paid on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if such units do not vest. Read SEC document |
| March 20, 2018 Filed Mar 21, 2018 20:37 UTC |
SHORT MARIANNE DEVP & Chief Legal Officer
|
GrantCommon Stock | 76.068 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-021094 · doc4.xml · nonDerivative · entry 1 SHORT MARIANNE D · CIK 0001565456 · EVP & Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,223.95 F1 · shares: Represents dividend equivalents paid on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if such units do not vest. Read SEC document |
| March 20, 2018 Filed Mar 21, 2018 20:38 UTC |
WICHMANN DAVID SDirector · Chief Executive Officer
|
GrantCommon Stock | 123.162 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-021095 · doc4.xml · nonDerivative · entry 1 WICHMANN DAVID S · CIK 0001268489 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 805,117.249 F1 · shares: Represents dividend equivalents paid on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if such units do not vest. Read SEC document |
| March 20, 2018 Filed Mar 21, 2018 20:39 UTC |
WILSON D ELLENEVP Human Capital
|
GrantCommon Stock | 67.8 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-021096 · doc4.xml · nonDerivative · entry 1 WILSON D ELLEN · CIK 0001633390 · EVP Human Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,327.67 F1 · shares: Represents dividend equivalents paid on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if such units do not vest. Read SEC document |
| March 19, 2018 Filed Mar 21, 2018 20:22 UTC |
BURKE RICHARD TDirector
|
SaleCommon Stock | 10,000 | $224.36 | $2,243,610.00 |
DisclosureSEC source: 0001209191-18-021075 · doc4.xml · nonDerivative · entry 1 BURKE RICHARD T · CIK 0000905023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,771,257 F1 · price: This transaction was executed in multiple trades ranging from $223.90 to $224.56 per share. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| March 15, 2018 Filed Mar 19, 2018 21:11 UTC |
RENFRO LARRY CVice Chmn, UHG and CEO, Optum
|
SaleCommon Stock | 22,184 | $228.94 | $5,078,804.96 |
DisclosureSEC source: 0001209191-18-020636 · doc4.xml · nonDerivative · entry 1 RENFRO LARRY C · CIK 0001235046 · Vice Chmn, UHG and CEO, Optum 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 173,228.63 F1 · price: This transaction was executed in multiple trades ranging from $225.885 to $230.740 per share. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the sales were effected. Read SEC document |
| March 15, 2018 Filed Mar 19, 2018 21:12 UTC |
Nelson Steven HEVP & CEO, UnitedHealthcare
|
SaleCommon Stock | 14,232.732 | $230.22 | $3,276,631.10 |
DisclosureSEC source: 0001209191-18-020640 · doc4.xml · nonDerivative · entry 1 Nelson Steven H · CIK 0001320490 · EVP & CEO, UnitedHealthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,219.456 F1 · price: This transaction was executed in multiple trades ranging from $230.12 to $230.455 per share. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the sales were effected. Read SEC document |
| March 01, 2018 Filed Mar 2, 2018 22:32 UTC |
BURKE RICHARD TDirector
|
SaleCommon Stock | 400 | $229.00 | $91,600.00 |
DisclosureSEC source: 0001209191-18-015873 · doc4.xml · nonDerivative · entry 2 BURKE RICHARD T · CIK 0000905023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,781,257 Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 22:32 UTC |
BURKE RICHARD TDirector
|
SaleCommon Stock | 10,000 | $229.90 | $2,299,016.00 |
DisclosureSEC source: 0001209191-18-015873 · doc4.xml · nonDerivative · entry 1 BURKE RICHARD T · CIK 0000905023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,781,657 F1 · price: This transaction was executed in multiple trades ranging from $229.22 to $231.11 per share. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the sales were effected. Read SEC document |
| February 16, 2018 Filed Feb 20, 2018 21:21 UTC |
BURKE RICHARD TDirector
|
Exercise / conversionNon-Qualified Stock Options (right to buy) · Derivative | 1,090 | $0.00 Strike: $48.08 | $0.00 |
DisclosureSEC source: 0001209191-18-011320 · doc4.xml · derivative · entry 3 BURKE RICHARD T · CIK 0000905023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,090 shares Expires 2018-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2018 Filed Feb 20, 2018 21:21 UTC |
BURKE RICHARD TDirector
|
Exercise / conversionCommon Stock | 1,090 | $48.08 | $52,407.20 |
DisclosureSEC source: 0001209191-18-011320 · doc4.xml · nonDerivative · entry 1 BURKE RICHARD T · CIK 0000905023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,791,657 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 13, 2018 Filed Feb 14, 2018 22:36 UTC |
HEMSLEY STEPHEN JDirector · Executive Chair of the Board
|
GrantNon-Qualified Stock Options (right to buy) · Derivative | 53,042 | $0.00 Strike: $226.64 | $0.00 |
DisclosureSEC source: 0001209191-18-010009 · doc4.xml · derivative · entry 10 HEMSLEY STEPHEN J · CIK 0001180162 · Director · Executive Chair of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,042 Underlying: Common Stock · 53,042 shares Expires 2028-02-13 F5 · derivative.exercise_date: The stock options vest at a rate of 25% annually on February 13 from the years 2019 through 2022. Read SEC document |
| February 13, 2018 Filed Feb 14, 2018 22:36 UTC |
HEMSLEY STEPHEN JDirector · Executive Chair of the Board
|
GrantCommon Stock | 9,928 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-010009 · doc4.xml · nonDerivative · entry 4 HEMSLEY STEPHEN J · CIK 0001180162 · Director · Executive Chair of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,547,620.321 F3 · shares: The restricted stock units vest at a rate of 25% annually on February 13 from the years 2019 through 2022. F4 · balance_after: Amount does not include performance-based restricted stock units granted to the executive officer on February 13, 2018, as performance awards not tied to stock price are not derivative securities for purposes of Section 16 under guidance from the staff of the SEC. The number of performance-based restricted stock units that the executive officer will receive will be determined at the end of the 3-year performance period and will be dependent upon the achievement of cumulative 3-year EPS and average return-on-equity performance metrics approved by the Compensation and Human Resources Committee. The target number of performance-based restricted stock units is 19,856. Read SEC document |
| February 13, 2018 Filed Feb 14, 2018 22:36 UTC |
HEMSLEY STEPHEN JDirector · Executive Chair of the Board
|
Tax withholdingCommon Stock | 22,694 | $226.64 | $5,143,368.16 |
DisclosureSEC source: 0001209191-18-010009 · doc4.xml · nonDerivative · entry 3 HEMSLEY STEPHEN J · CIK 0001180162 · Director · Executive Chair of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,537,692.321 F2 · shares: Represents the withholding of shares to satisfy tax obligations upon the settlement of Performance Share Awards for the performance period 2015-2017. Read SEC document |
| February 13, 2018 Filed Feb 14, 2018 22:36 UTC |
HEMSLEY STEPHEN JDirector · Executive Chair of the Board
|
GrantCommon Stock | 49,767 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-010009 · doc4.xml · nonDerivative · entry 2 HEMSLEY STEPHEN J · CIK 0001180162 · Director · Executive Chair of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,560,386.321 F1 · shares: Represents the settlement of Performance Share Awards for the performance period 2015-2017. Read SEC document |
| February 13, 2018 Filed Feb 14, 2018 22:34 UTC |
Nelson Steven HEVP & CEO, UnitedHealthcare
|
GrantNon-Qualified Stock Options (right to buy) · Derivative | 39,781 | $0.00 Strike: $226.64 | $0.00 |
DisclosureSEC source: 0001209191-18-010010 · doc4.xml · derivative · entry 5 Nelson Steven H · CIK 0001320490 · EVP & CEO, UnitedHealthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,781 Underlying: Common Stock · 39,781 shares Expires 2028-02-13 F5 · derivative.exercise_date: The stock options vest at a rate of 25% annually on February 13 from the years 2019 through 2022. Read SEC document |
| February 13, 2018 Filed Feb 14, 2018 22:34 UTC |
Nelson Steven HEVP & CEO, UnitedHealthcare
|
GrantCommon Stock | 7,446 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-010010 · doc4.xml · nonDerivative · entry 4 Nelson Steven H · CIK 0001320490 · EVP & CEO, UnitedHealthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,452.188 F3 · shares: The restricted stock units vest at a rate of 25% annually on February 13 from the years 2019 through 2022. F4 · balance_after: Amount does not include Performance Share Awards granted to the executive officer on February 13, 2018, as performance awards not tied to stock price are not derivative securities for purposes of Section 16 under guidance from the staff of the SEC. The number of Performance Shares that the executive officer will receive will be determined at the end of the 3-year performance period and will be dependent upon the achievement of cumulative 3-year EPS and average return-on-equity performance metrics approved by the Compensation and Human Resources Committee. The target number of Performance Awards is 14,892. Read SEC document |
| February 13, 2018 Filed Feb 14, 2018 22:34 UTC |
Nelson Steven HEVP & CEO, UnitedHealthcare
|
Tax withholdingCommon Stock | 7,525 | $226.64 | $1,705,466.00 |
DisclosureSEC source: 0001209191-18-010010 · doc4.xml · nonDerivative · entry 3 Nelson Steven H · CIK 0001320490 · EVP & CEO, UnitedHealthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,006.188 F2 · shares: Represents the withholding of shares to satisfy tax obligations upon the settlement of Performance Share Awards for the performance period 2015-2017. Read SEC document |
| February 13, 2018 Filed Feb 14, 2018 22:34 UTC |
Nelson Steven HEVP & CEO, UnitedHealthcare
|
GrantCommon Stock | 16,501 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-010010 · doc4.xml · nonDerivative · entry 2 Nelson Steven H · CIK 0001320490 · EVP & CEO, UnitedHealthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,531.188 F1 · shares: Represents the settlement of Performance Share Awards for the performance period 2015-2017. Read SEC document |
| February 13, 2018 Filed Feb 14, 2018 22:38 UTC |
RENFRO LARRY CVice Chmn, UHG and CEO, Optum
|
GrantNon-Qualified Stock Options (right to buy) · Derivative | 49,505 | $0.00 Strike: $226.64 | $0.00 |
DisclosureSEC source: 0001209191-18-010024 · doc4.xml · derivative · entry 5 RENFRO LARRY C · CIK 0001235046 · Vice Chmn, UHG and CEO, Optum 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,505 Underlying: Common Stock · 49,505 shares Expires 2028-02-13 F5 · derivative.exercise_date: The stock options vest at a rate of 25% annually on February 13 from the years 2019 through 2022. Read SEC document |
| February 13, 2018 Filed Feb 14, 2018 22:38 UTC |
RENFRO LARRY CVice Chmn, UHG and CEO, Optum
|
GrantCommon Stock | 9,266 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-010024 · doc4.xml · nonDerivative · entry 4 RENFRO LARRY C · CIK 0001235046 · Vice Chmn, UHG and CEO, Optum 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195,412.63 F3 · shares: The restricted stock units vest at a rate of 25% annually on February 13 from the years 2019 through 2022. F4 · balance_after: Amount does not include Performance Share Awards granted to the executive officer on February 13, 2018, as performance awards not tied to stock price are not derivative securities for purposes of Section 16 under guidance from the staff of the SEC. The number of Performance Shares that the executive officer will receive will be determined at the end of the 3-year performance period and will be dependent upon the achievement of cumulative 3-year EPS and average return-on-equity performance metrics approved by the Compensation and Human Resources Committee. The target number of Performance Shares is 18,532. Read SEC document |
| February 13, 2018 Filed Feb 14, 2018 22:38 UTC |
RENFRO LARRY CVice Chmn, UHG and CEO, Optum
|
Tax withholdingCommon Stock | 15,616 | $226.64 | $3,539,210.24 |
DisclosureSEC source: 0001209191-18-010024 · doc4.xml · nonDerivative · entry 3 RENFRO LARRY C · CIK 0001235046 · Vice Chmn, UHG and CEO, Optum 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 186,146.63 F2 · shares: Represents the withholding of shares to satisfy tax obligations upon the settlement of Performance Share Awards for the performance period 2015-2017. Read SEC document |
| February 13, 2018 Filed Feb 14, 2018 22:38 UTC |
RENFRO LARRY CVice Chmn, UHG and CEO, Optum
|
GrantCommon Stock | 35,130 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-010024 · doc4.xml · nonDerivative · entry 2 RENFRO LARRY C · CIK 0001235046 · Vice Chmn, UHG and CEO, Optum 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 201,762.63 F1 · shares: Represents the settlement of Performance Share Awards for the performance period 2015-2017. Read SEC document |
| February 13, 2018 Filed Feb 14, 2018 22:38 UTC |
REX JOHN FEVP Chief Financial Officer
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 29,468 | $0.00 Strike: $226.64 | $0.00 |
DisclosureSEC source: 0001209191-18-010033 · doc4.xml · derivative · entry 5 REX JOHN F · CIK 0001676672 · EVP Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,468 Underlying: Common Stock · 29,468 shares Expires 2028-02-13 F5 · derivative.exercise_date: The stock options vest at a rate of 25% annually on February 13 from the years 2019 through 2022. Read SEC document |
| February 13, 2018 Filed Feb 14, 2018 22:38 UTC |
REX JOHN FEVP Chief Financial Officer
|
GrantCommon Stock | 5,516 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-010033 · doc4.xml · nonDerivative · entry 4 REX JOHN F · CIK 0001676672 · EVP Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,651.435 F3 · shares: The restricted stock units vest at a rate of 25% annually on February 13 from the years 2019 through 2022. F4 · balance_after: Amount does not include Performance Share Awards granted to the executive officer on February 13, 2018, as performance awards not tied to stock price are not derivative securities for purposes of Section 16 under guidance from the staff of the SEC. The number of Performance Shares that the executive officer will receive will be determined at the end of the 3-year performance period and will be dependent upon the achievement of cumulative 3-year EPS and average return-on-equity performance metrics approved by the Compensation and Human Resources Committee. The target number of Performance Share Awards is 11,031. Read SEC document |
| February 13, 2018 Filed Feb 14, 2018 22:38 UTC |
REX JOHN FEVP Chief Financial Officer
|
Tax withholdingCommon Stock | 6,024 | $226.64 | $1,365,279.36 |
DisclosureSEC source: 0001209191-18-010033 · doc4.xml · nonDerivative · entry 3 REX JOHN F · CIK 0001676672 · EVP Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,135.435 F2 · shares: Represents the withholding of shares to satisfy tax obligations upon the settlement of Performance Share Awards for the performance period 2015-2017. Read SEC document |
| February 13, 2018 Filed Feb 14, 2018 22:38 UTC |
REX JOHN FEVP Chief Financial Officer
|
GrantCommon Stock | 12,243 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-010033 · doc4.xml · nonDerivative · entry 2 REX JOHN F · CIK 0001676672 · EVP Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,159.435 F1 · shares: Represents the settlement of Performance Share Awards for the performance period 2015-2017. Read SEC document |
| February 13, 2018 Filed Feb 14, 2018 22:39 UTC |
WILSON D ELLENEVP Human Capital
|
GrantNon-Qualified Stock Options (right to buy) · Derivative | 20,628 | $0.00 Strike: $226.64 | $0.00 |
DisclosureSEC source: 0001209191-18-010041 · doc4.xml · derivative · entry 6 WILSON D ELLEN · CIK 0001633390 · EVP Human Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,628 Underlying: Common Stock · 20,628 shares Expires 2028-02-13 F6 · derivative.exercise_date: The stock options vest at a rate of 25% annually on February 13 from the years 2019 through 2022. Read SEC document |
| February 13, 2018 Filed Feb 14, 2018 22:39 UTC |
WILSON D ELLENEVP Human Capital
|
GrantCommon Stock | 8,825 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-010041 · doc4.xml · nonDerivative · entry 5 WILSON D ELLEN · CIK 0001633390 · EVP Human Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,259.87 F4 · shares: The restricted stock units vest 100% on the second anniversary of the grant date. F5 · balance_after: Amount does not include Performance Share Awards granted to the executive officer on February 13, 2018, as performance awards not tied to stock price are not derivative securities for purposes of Section 16 under guidance from the staff of the SEC. The number of Performance Shares that the executive officer will receive will be determined at the end of the 3-year performance period and will be dependent upon the achievement of cumulative 3-year EPS and average return-on-equity performance metrics approved by the Compensation and Human Resources Committee. The target number of Performance Shares is 7,722. Read SEC document |
| February 13, 2018 Filed Feb 14, 2018 22:39 UTC |
WILSON D ELLENEVP Human Capital
|
GrantCommon Stock | 3,861 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-010041 · doc4.xml · nonDerivative · entry 4 WILSON D ELLEN · CIK 0001633390 · EVP Human Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,434.87 F3 · shares: The restricted stock units vest at a rate of 25% annually on February 13 from the years 2019 through 2022. Read SEC document |
| February 13, 2018 Filed Feb 14, 2018 22:39 UTC |
WILSON D ELLENEVP Human Capital
|
Tax withholdingCommon Stock | 5,856 | $226.64 | $1,327,203.84 |
DisclosureSEC source: 0001209191-18-010041 · doc4.xml · nonDerivative · entry 3 WILSON D ELLEN · CIK 0001633390 · EVP Human Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,573.87 F2 · shares: Represents the withholding of shares to satisfy tax obligations upon the settlement of Performance Share Awards for the performance period 2015-2017. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.